Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination
September 12, 2022 09:15 ET
|
Aesther Healthcare Acquisition Corp.
New York, NY and Providence, RI, Sept. 12, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 30, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into...
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce $75 Million Common Stock Purchase Transaction with White Lion Capital
September 08, 2022 08:07 ET
|
Aesther Healthcare Acquisition Corp.
NEWS PROVIDED BY Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) September 8, 2022, 07:45 am ET NEW YORK and PROVIDENCE, R.I., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition...
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA)
September 06, 2022 07:59 ET
|
Ocean Biomedical, Inc.
Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol, “OCEA”....
Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors Which Kill Glioblastoma and Block the Metastasis of Malignant Melanoma Cells to the Lung By Over 90% Announced by Ocean Biomedical and Aesther Healthcare (NASDAQ: AEHA)
September 06, 2022 07:45 ET
|
Aesther Healthcare Acquisition Corp.
• Ocean Biomedical will be a wholly owned subsidiary of Aesther Healthcare Acquisition Corp. and will change its name to Ocean Biomedical, Inc., expected to be listed on NASDAQ under the symbol,...
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
August 31, 2022 07:47 ET
|
Aesther Healthcare Acquisition Corp.
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.Ocean...
Aesther Healthcare Acquisition Corp. Has Entered Into an Agreement and Plan of Merger with Ocean Biomedical, Inc., a Next-Generation Biopharma Company, to List on NASDAQ
August 31, 2022 07:45 ET
|
Ocean Biomedical, Inc.
Ocean Biomedical’s innovative business model bridges the ‘bench-to-bedside’ gap by accelerating the commercialization of innovative assets from research universities and medical centers.Ocean...
Aesther Healthcare Acquisition Corp. Announces Separate Trading of its Class A Common Stock and Warrants to Commence on November 5, 2021
November 03, 2021 16:35 ET
|
Aesther Healthcare Acquisition Corp.
NEW YORK, NY, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) today announced that, commencing November 5, 2021, holders of the units sold in...
Aesther Healthcare Acquisition Corp. Announces Closing of Initial Public Offering and Partial Exercise of Over-Allotment Option
September 17, 2021 13:30 ET
|
Aesther Healthcare Acquisition Corp.
New York, NY, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Aesther Healthcare Acquisition Corp. (Nasdaq: AEHAU) (the “Company”) announced today the closing of its initial public offering of 10,000,000 units...
Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering
June 10, 2021 08:59 ET
|
Ocean Biomedical, Inc.
PROVIDENCE, R.I., June 10, 2021 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (“Ocean”) today announced that it has publicly filed a Registration Statement on Form S-1 (the “Registration Statement”)...